Recognition highlights BostonGene's leadership in improving drug development decisions,reducing risk and accelerating patient impactSAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost &…
Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune BiologySAN…
BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages…